Peptide Legal Status in Oregon
Enhanced state-level restrictions on compounding and distribution. Oregon's Board of Pharmacy enforces strict compounding rules and requires additional state-level registration for pharmacies producing compounded peptides. The state actively monitors research chemical sales.
Key Facts
Oregon Regulatory Details
Peptide Availability in Oregon
| Peptide | FDA Status | Evidence | Availability |
|---|---|---|---|
| BPC-157 | Not Approved | C | Restricted |
| TB-500 (Thymosin Beta-4) | Not Approved | C | Restricted |
| GHK-Cu | Not Approved | B | Restricted |
| Ipamorelin | Not Approved | B | Restricted |
| CJC-1295 | Not Approved | B | Restricted |
| Sermorelin | Approved | A | Available by Rx |
| Tesamorelin | Approved | A | Available by Rx |
| Bremelanotide (PT-141) | Approved | A | Available by Rx |
| Semaglutide | Approved | A | Available by Rx |
| Tirzepatide | Approved | A | Available by Rx |
| AOD-9604 | Not Approved | C | Restricted |
| DSIP (Delta Sleep-Inducing Peptide) | Not Approved | D | Restricted |
| Epithalon (Epitalon) | Not Approved | C | Restricted |
| Selank | Not Approved | B | Restricted |
| Semax | Not Approved | B | Restricted |
| GHRP-2 | Not Approved | B | Restricted |
| GHRP-6 | Not Approved | B | Restricted |
| Hexarelin | Not Approved | B | Restricted |
| Melanotan II | Not Approved | C | Restricted |
| LL-37 | Not Approved | C | Restricted |
| Thymalin | Not Approved | C | Restricted |
| KPV | Not Approved | D | Restricted |
| Liraglutide | Approved | A | Available by Rx |
| Retatrutide | Not Approved | B | Restricted |
| Survodutide | Not Approved | B | Restricted |
Peptides in Oregon: FAQ
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.